Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100383128C discloses an efficient route for capecitabine intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel chiral auxiliary method for Lamivudine production offering superior stereocontrol and simplified purification for reliable pharmaceutical intermediate supply chains.
Novel bicyclic analogues of OSW-1 saponins with potent antitumor activity via efficient synthetic pathway ensuring high purity and supply stability.
Novel patent CN106831927B enables high stereoselective synthesis. Offers reliable supply chain and cost reduction in pharmaceutical intermediate manufacturing for global partners.
Patent CN101307048A details a novel stereoselective method for Lamivudine using chiral auxiliaries, offering superior purity and cost-effective manufacturing for global supply chains.
Innovative 11-step synthetic route for high-purity H4 alkaloid ensures scalable supply for NAFLD therapeutics, overcoming natural extraction limitations effectively.
Patent CN1428345A details a safer gastrodin synthesis route eliminating red phosphorus. Achieve cost reduction in API manufacturing with scalable, high-purity phenolic glycosides.
Patent CN103113441A details a cost-effective Capecitabine synthesis using silylation and glycosylation, offering significant supply chain advantages for API manufacturers.
Patent CN110041377B details a novel synthetic method for O-mannan core structures M1, M2, and M3, offering high regioselectivity and scalable production for pharmaceutical intermediates.
Patent CN101712708A reveals a scalable Decitabine synthesis using pivaloyl protection, eliminating chromatography for significant cost reduction and high purity.
Novel patent CN118955585A offers scalable D-mannosamine production. Reduces purification steps, enhances supply chain reliability for pharmaceutical intermediates.
Patent CN111172128A reveals efficient sucrose phosphorylase method for AA-2G. Enhances stability and supply chain reliability for cosmetic and food industries.
Patent CN102241710A reveals efficient glycosylation routes for salidroside derivatives, offering cost-effective solutions for neuroprotective drug development and supply chain stability.
Patent CN101824057A details a scalable four-step route for O-glycoside nitrones, offering cost reduction in pharmaceutical intermediate manufacturing via mild glycosylation.
Patent CN104945363B reveals a scalable synthesis for SGLT2 inhibitor intermediates, offering cost-effective alternatives to conventional dapagliflozin-based routes for pharmaceutical supply chains.
Discover advanced synthesis methods for water-soluble Rebeccamycin analogues. Enhance anticancer drug development with reliable pharmaceutical intermediate supply and cost-effective manufacturing.
Patent CN1571792A details a cost-effective 10-step synthesis of L-FMAU from L-arabinose using Selectfluor, offering superior yields over conventional ribose routes.
Patent CN108409818B reveals a high-yield cytidine synthesis route eliminating tin tetrachloride. Discover cost-effective manufacturing and supply chain advantages for nucleoside intermediates.
Patent CN103923133A enables one-pot alpha-arbutin synthesis. Enhances supply reliability and reduces manufacturing complexity for cosmetic and pharma intermediates.
Patent CN109336856A details a mild synthesis route for 6-bromo-D-glucal. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.